| Q33391857 | An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma. |
| Q33798842 | Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand up 2 cancer study |
| Q91580912 | Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer |
| Q33414664 | Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumors |
| Q34560933 | Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer |
| Q33997258 | Phase II study of erlotinib in patients with advanced biliary cancer |
| Q34606724 | Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841. |
| Q33670963 | Rehabilitation challenges in multiple sclerosis |
| Q71659588 | Reversible alexia without agraphia due to migraine |
| Q98301886 | Targeting of the Hedgehog/GLI and mTOR pathways in advanced pancreatic cancer, a phase 1 trial of Vismodegib and Sirolimus combination |